Novartis Raises 2026 Profit Outlook Despite $2.2 Billion Drug Setbacks — What the Numbers Really Show
Novartis lifted its 2026 adjusted profit outlook even as $2.2 billion in drug-program charges hit reported earnings. Here is why both numbers matter.